1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	483_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	483_QUEST_clinical_caseMIR	SENT1	-	-
3	64	64		-	-	9-11	483_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	483_QUEST_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	16-17	483_QUEST_clinical_caseMIR	SENT1	-	-
6	sin	sin	SPS00	C0332288	atributo	18-21	483_QUEST_clinical_caseMIR	SENT1	-	-
7	comorbilidades	comorbilidades	NC00SC0	C1275743	hallazgo	22-36	483_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	Negacion
8	relevantes	relevante	AQ0CP0	-	-	37-47	483_QUEST_clinical_caseMIR	SENT1	-	-
9	.	.	Fp	-	-	47-48	483_QUEST_clinical_caseMIR	SENT1	-	-
10	intervenida	intervenir	VMP00SF	-	-	49-60	483_QUEST_clinical_caseMIR	SENT1	-	-
11	de	de	SPS00	C0332285	atributo	61-63	483_QUEST_clinical_caseMIR	SENT1	-	-
12	un	un		C0205447_1	calificador_1	64-66	483_QUEST_clinical_caseMIR	SENT1	-	-
13	cáncer	cáncer	NCMS000	C0006142#C0678222_1	trastorno_1	67-73	483_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	de	de	SPS00	C0006142#C0678222_2	trastorno_2	74-76	483_QUEST_clinical_caseMIR	SENT1	-	-
15	mama	mamar	VMM02S0	C0006142#C0678222_3	trastorno_3	77-81	483_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
16	derecha	derecho	AQ0FS0	C0445291#C0445292#C0205090#C0450415	calificador	82-89	483_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
17	mediante	mediante	SPS00	-	-	90-98	483_QUEST_clinical_caseMIR	SENT1	-	-
18	una	una		C0205447_1	calificador_1	99-102	483_QUEST_clinical_caseMIR	SENT1	-	-
19	tumorectomía	tumorectomía	NC00SC0	C0851238	procedimiento	103-115	483_QUEST_clinical_caseMIR	SENT1	-	-
20	ampliada	ampliar	VMP00SF	-	-	116-124	483_QUEST_clinical_caseMIR	SENT1	-	-
21	y	y	CC	C1706368	calificador	125-126	483_QUEST_clinical_caseMIR	SENT1	-	-
22	biopsia	biopsia	NCFS000	C0005558	procedimiento#calificador	127-134	483_QUEST_clinical_caseMIR	SENT1	-	-
23	selectiva	selectivo	AQ0FS0	-	-	135-144	483_QUEST_clinical_caseMIR	SENT1	-	-
24	del	del	SP+DA	-	-	145-148	483_QUEST_clinical_caseMIR	SENT1	-	-
25	ganglio	ganglio	NCMS000	C0272401#C0677944_1	trastorno_1	149-156	483_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
26	centinela	centinela	NCCS000	C0272401#C0677944_2	trastorno_2	157-166	483_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
27	,	,	Fc	-	-	166-167	483_QUEST_clinical_caseMIR	SENT1	-	-
28	con	con	SPS00	C0332287	atributo	168-171	483_QUEST_clinical_caseMIR	SENT1	-	-
29	el	el	DA0MS0	-	-	172-174	483_QUEST_clinical_caseMIR	SENT1	-	-
30	siguiente	siguiente	NC00SC0	C0332282	atributo	175-184	483_QUEST_clinical_caseMIR	SENT1	-	-
31	resultado	resultado	NCMS000	C1704419#C1280500#C1280519#C1274040	concepto_para_navegación	185-194	483_QUEST_clinical_caseMIR	SENT1	-	-
32	anatomopatológi_x0002_co	anatomopatológi_x0002_co		-	-	195-219	483_QUEST_clinical_caseMIR	SENT1	-	-
33	.	.	Fp	-	-	219-220	483_QUEST_clinical_caseMIR	SENT1	-	-
34	carcinoma	carcinoma	NCMS000	C1412014#C1176475_1	anomalía_morfológica_1	221-230	483_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
35	ductal	ductal		C1412014#C1176475_2	anomalía_morfológica_2	231-237	483_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
36	infiltrante	infiltrante	AQ0CS0	C1412014#C1176475_3	anomalía_morfológica_3	238-249	483_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
37	pobremente	pobremente	RG	C0205169	calificador	250-260	483_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
38	diferenciado	diferenciar	VMP00SM	-	-	261-273	483_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
39	(	(	Fpa	-	-	274-275	483_QUEST_clinical_caseMIR	SENT1	-	-
40	grado	grado	NCMS000	C0450094_1	calificador_1	275-280	483_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
41	3	3	Z	C0450094_2	calificador_2	281-282	483_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
42	)	)	Fpt	-	-	282-283	483_QUEST_clinical_caseMIR	SENT1	-	-
43	,	,	Fc	-	-	283-284	483_QUEST_clinical_caseMIR	SENT1	-	-
44	tamaño	tamaño	NCMS000	C3714679#C0456389	calificador#atributo	285-291	483_QUEST_clinical_caseMIR	SENT1	-	-
45	de	de	SPS00	C0332285	atributo	292-294	483_QUEST_clinical_caseMIR	SENT1	-	-
46	2.2	2.2	Z	-	-	295-298	483_QUEST_clinical_caseMIR	SENT1	-	-
47	cm	cm	NCMN000	-	-	299-301	483_QUEST_clinical_caseMIR	SENT1	-	-
48	(	(	Fpa	-	-	302-303	483_QUEST_clinical_caseMIR	SENT1	-	-
49	pT2	pT2		-	-	303-306	483_QUEST_clinical_caseMIR	SENT1	-	-
50	)	)	Fpt	-	-	306-307	483_QUEST_clinical_caseMIR	SENT1	-	-
51	.	.	Fp	-	-	307-308	483_QUEST_clinical_caseMIR	SENT1	-	-
52	receptores	receptor	NCMP000	C0597357	sustancia	309-319	483_QUEST_clinical_caseMIR	SENT1	-	-
53	de	de	SPS00	C0332285	atributo	320-322	483_QUEST_clinical_caseMIR	SENT1	-	-
54	estrógenos	estrógeno	NCMP000	C0014939	sustancia	323-333	483_QUEST_clinical_caseMIR	SENT1	-	-
55	y	y	CC	C1706368	calificador	334-335	483_QUEST_clinical_caseMIR	SENT1	-	-
56	progesterona	progesterona	NCFS000	C0033308	sustancia	336-348	483_QUEST_clinical_caseMIR	SENT1	-	-
57	positivos	positivo	AQ0MP0	C1446409	calificador	349-358	483_QUEST_clinical_caseMIR	SENT1	-	-
58	.	.	Fp	-	-	358-359	483_QUEST_clinical_caseMIR	SENT1	-	-

1	Ki67	Ki67		-	-	360-364	483_QUEST_clinical_caseMIR	SENT2	-	-
2	25	25	Z	-	-	365-367	483_QUEST_clinical_caseMIR	SENT2	-	-
3	%	%	Ft	-	-	367-368	483_QUEST_clinical_caseMIR	SENT2	-	-
4	.	.	Fp	-	-	368-369	483_QUEST_clinical_caseMIR	SENT2	-	-

1	HER2	HER2		-	-	370-374	483_QUEST_clinical_caseMIR	SENT3	-	-
2	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	375-383	483_QUEST_clinical_caseMIR	SENT3	-	-
3	.	.	Fp	-	-	383-384	483_QUEST_clinical_caseMIR	SENT3	-	-

1	Presenta	presentar	VMIP3S0	-	-	385-393	483_QUEST_clinical_caseMIR	SENT4	-	-
2	afectación	afectación	NCFS000	-	-	394-404	483_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
3	macroscópica	macroscópico	AQ0FS0	C0439806	calificador	405-417	483_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
4	del	del	SP+DA	-	-	418-421	483_QUEST_clinical_caseMIR	SENT4	-	-
5	ganglio	ganglio	NCMS000	C0272401#C0677944_1	trastorno_1	422-429	483_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
6	centinela	centinela	NCCS000	C0272401#C0677944_2	trastorno_2	430-439	483_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
7	,	,	Fc	-	-	439-440	483_QUEST_clinical_caseMIR	SENT4	-	-
8	aunque	aunque	CC	-	-	441-447	483_QUEST_clinical_caseMIR	SENT4	-	-
9	no	no	RN	C1298908	calificador	448-450	483_QUEST_clinical_caseMIR	SENT4	-	-
10	hay	haber	VMIP3S0	-	-	451-454	483_QUEST_clinical_caseMIR	SENT4	-	-
11	afectación	afectación	NCFS000	-	-	455-465	483_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	Negacion
12	del	del	SP+DA	-	-	466-469	483_QUEST_clinical_caseMIR	SENT4	-	-
13	resto	resto	NCMS000	-	-	470-475	483_QUEST_clinical_caseMIR	SENT4	-	-
14	de	de	SPS00	C0332285	atributo	476-478	483_QUEST_clinical_caseMIR	SENT4	-	-
15	ganglios	ganglio	NCMP000	-	-	479-487	483_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
16	axilares	axilar	AQ0CP0	C0004454	calificador	488-496	483_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
17	aislados	aislar	VMP00PM	-	-	497-505	483_QUEST_clinical_caseMIR	SENT4	-	-
18	(	(	Fpa	-	-	506-507	483_QUEST_clinical_caseMIR	SENT4	-	-
19	pN1	pN1		-	-	507-510	483_QUEST_clinical_caseMIR	SENT4	-	-
20	)	)	Fpt	-	-	510-511	483_QUEST_clinical_caseMIR	SENT4	-	-
21	.	.	Fp	-	-	511-512	483_QUEST_clinical_caseMIR	SENT4	-	-

1	Qué	qué	DE0CN0	-	-	513-516	483_QUEST_clinical_caseMIR	SENT5	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	517-528	483_QUEST_clinical_caseMIR	SENT5	-	-
3	sistémico	sistémico	AQ0MS0	C0205373	calificador	529-538	483_QUEST_clinical_caseMIR	SENT5	-	-
4	adyuvante	adyuvante	AQ0CS0	C0001551	sustancia	539-548	483_QUEST_clinical_caseMIR	SENT5	-	-
5	considera	considerar	VMIP3S0	-	-	549-558	483_QUEST_clinical_caseMIR	SENT5	-	-
6	más	más	RG	C0205172	calificador	559-562	483_QUEST_clinical_caseMIR	SENT5	-	-
7	adecuado	adecuar	VMP00SM	-	-	563-571	483_QUEST_clinical_caseMIR	SENT5	-	-
8	para	para	SPS00	C0521125	calificador	572-576	483_QUEST_clinical_caseMIR	SENT5	-	-
9	esta	este	DD0FS0	-	-	577-581	483_QUEST_clinical_caseMIR	SENT5	-	-
10	paciente	paciente	NCCS000	C0030705	persona	582-590	483_QUEST_clinical_caseMIR	SENT5	-	-
11	.	.	Fp	-	-	590-591	483_QUEST_clinical_caseMIR	SENT5	-	-

